Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Greg was also central to the planning, design, and construction of this facility
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Additional data from APPRAISE ATP trial reinforce modular therapy approach
The collaboration aims to bolster healthcare entrepreneurship
The funds raised from the Whitathon run are utilized to treat underprivileged children suffering from Retinoblastoma
Subscribe To Our Newsletter & Stay Updated
